New Diabetes Drug a Success, Says Eli Lilly
New Diabetes drug a success, says Eli Lilly
Filed under: drug rehab treatment methods
A new drug from Eli Lilly to treat Type-2 Diabetes is one step closer to hitting the market. The drug maker said the Dulaglutide met its goals in a pair of late-phase studies. The drug is a once-a-week injection that lowers blood glucose. Right now …
Read more on Fox 59
Stocks to Watch: EBay, SanDisk, Theravance
Filed under: drug rehab treatment methods
Glaxo and its partner Theravance Inc. (THRX) are seeking approval from the U.S. Food and Drug Administration for Breo Ellipta, a once-daily inhaled drug to treat COPD. Theravance shares–which were halted ahead of Wednesday's close–surged 17% to …
Read more on Wall Street Journal (blog)
Resverlogix Completes Dosing In ASSURE Clinical Trial
Filed under: drug rehab treatment methods
Resverlogix is developing RVX-208, a first-in-class small molecule for the treatment of atherosclerosis. RVX-208 is the first BET bromodomain inhibitor in clinical trials. This drug also has the potential to treat other indications, including diabetes …
Read more on Canada NewsWire (press release)